Abstract
PEX19 binding sites are essential parts of the targeting signals of peroxisomal membrane proteins (mPTS). In this study, we characterized PEX19 binding sites of PEX11, the most abundant peroxisomal and glycosomal membrane protein from Trypanosoma brucei and Saccharomyces cerevisiae. TbPEX11 contains two PEX19 binding sites, one close to the N-terminus (BS1) and a second in proximity to the first transmembrane domain (BS2). The N-terminal BS1 is highly conserved across different organisms and is required for maintenance of the steady-state concentration and efficient targeting to peroxisomes and glycosomes in both baker’s yeast and Trypanosoma brucei. The second PEX19 binding site in TbPEX11 is essential for its glycosomal localization. Deletion or mutations of the PEX19 binding sites in TbPEX11 or ScPEX11 results in mislocalization of the proteins to mitochondria. Bioinformatic analysis indicates that the N-terminal region of TbPEX11 contains an amphiphilic helix and several putative TOM20 recognition motifs. We show that the extreme N-terminal region of TbPEX11 contains a cryptic N-terminal signal that directs PEX11 to the mitochondrion if its glycosomal transport is blocked.
1 Introduction
Peroxisomes are single membrane bound organelles performing a wide range of functions (; ). Glyoxysomes in plants, Woronin bodies in fungi, and glycosomes in trypanosomatid parasites are specialized forms of peroxisomes (; ; ). Peroxisomes can multiply by growth and division, or they can form de novo from pre-peroxisomal vesicles that are supposed to bud from the endoplasmic reticulum (; ). Peroxisomes import matrix as well as membrane proteins post-translationally (; ; ; ). The import depends on a machinery of Peroxins (PEX proteins) and requires the presence of peroxisomal targeting signals in the cargo proteins (; ; ). Biogenesis of peroxisomes requires two distinct machineries for protein targeting: The first is responsible for the formation of the peroxisomal membrane by the targeting and insertion of peroxisomal membrane proteins (PMPs), and the second machinery is responsible for the import of peroxisomal matrix proteins (reviewed in ()). The trafficking of proteins destined for the peroxisome matrix has been well studied. A striking feature is that peroxisomes can import folded, even oligomeric proteins (; ). Peroxisomal matrix proteins contain type 1 or type 2 peroxisomal targeting signals (PTS1/PTS2) at the extreme C-terminus or close to the N-terminus, respectively (; ; ). Some proteins contain internal targeting signals () and some are transported by piggy-backing onto a PTS-containing protein (). The import of peroxisomal matrix proteins depends on cycling receptors that recognize peroxisomal proteins via their PTS in the cytosol and target them to a docking complex at the peroxisomal membrane. Import takes place through a transient pore or hydrogel-filled pore in an unknown fashion (; ; ). The cargo-unloaded receptors are mono-ubiquitinated and released to the cytosol for another round of import in an ATP-dependent manner by the peroxisomal exportomer (; ). The machinery that is responsible for the topogenesis of membrane proteins is distinct from the import machinery for matrix proteins (Reviewed in (; )). Only three peroxins with a direct role in PMP targeting have been identified, namely, PEX3 (), PEX16 in mammals (; ), and PEX19 () (Also reviewed in ()). In cells lacking any of these proteins, PMPs are either degraded or mistargeted to other subcellular compartments such as mitochondria, endoplasmic reticulum (ER), and membranes of unknown origin (; ; ). PMPs contain multiple binding sites (BSs) for the cytosolic receptor and chaperone PEX19 (). These binding sites are essential for targeting of the PMPs to the peroxisomal membrane, as they can function as mPTS i.e., membrane peroxisome targeting signal (). The mPTS often comprises part of the transmembrane domains and a short adjacent sequence, which contains either a cluster of basic residues or a mixture of basic and hydrophobic amino acids () (Reviewed in (; ; )). Rottensteiner et al., developed PEX19 binding site prediction methodology using peptide arrays (). Unlike PTS1 and PTS2 signals, which can be predicted more reliably (; ), PEX19 BSs are comparatively degenerate and can be present multiple times in a PMP. Therefore, an efficient PEX19BS predictor is still needed. Nonetheless, PEX19 binding sites (BSs) have been identified in various yeast, human and parasite PMPs, which shows evolutionary conservation across eukaryotes (; ). In most eukaryotes, PEX19 harbors a farnesylation motif (CaaX box), and farnesylation has been shown to increase the binding efficiency of PMPs (). However, trypanosomatid parasite PEX19 proteins lack such a CaaX motif ().
PEX11 is an integral peroxisomal membrane protein with at least two predicted alpha-helical transmembrane domains and both termini facing the cytosol (; ; ; ). In the yeast Saccharomyces cerevisiae, Pex11p, Pex25p, and Pex27p are the three members of the PEX11 protein family (; ; ). Similarly, mammals also encode three PEX11-family proteins namely, PEX11α, PEX11β, and PEX11γ (; ). In plants, there are five PEX11 homologs, for e. g., in Arabidopsis thaliana AtPEX11a, -b, -c, -d, and -e (). PEX11 family proteins are involved in the proliferation of peroxisome in yeasts, plants, and mammals (; ; ; ; ). Deletion of PEX11 in yeast has an effect on the β-oxidation of fatty acids, which can be due to defects in the transport of metabolites across the peroxisomal membrane (). PEX11β is widely expressed in mammalian tissues and it has a well-recognized function in the initial phase of peroxisomal fission when it remodels and elongates peroxisomal membranes (; ; ). The functions of PEX11α and PEX11γ are less clear (). Of the PEX11 proteins in mammals, only PEX11β deficiency was associated with the pathology of peroxisome biogenesis disorders (PBDs) (; ; ).
In trypanosomes, three PEX11 family proteins are known, namely, PEX11, GIM5A and GIM5B (; ; ). Like in mammals, yeast, and plants, both N- and C-termini of TbPEX11 are exposed to the cytosol (). Overexpression of TbPEX11 induces growth inhibition and transforms the globular glycosomes into long tubule clusters that occupy a large portion of the cytoplasm (). Accordingly, TbPEX11 appears to play a role in the proliferation of glycosomes in trypanosomes like its homologs in yeast and mammalian cells () (Reviewed in ()). PEX11 and both GIM5 proteins are essential for the survival of parasites (; ). At primary sequence level, PEX11 family proteins contain several conserved helices particularly in the N-terminal region (; ). PEX19 binding sites have been identified in various glycosomal membrane proteins (), but not in TbPEX11. Therefore, in this study, we characterized PEX19 binding sites of PEX11 from Trypanosoma brucei and Saccharomyces cerevisiae. TbPEX11 contains two PEX19 binding sites, the N-terminal PEX19 binding site (BS1) in PEX11 is highly conserved across different organisms and is required for maintenance of the steady-state concentration as well as efficient targeting to peroxisomes and glycosomes in both baker’s yeast and T. brucei. Deletion or mutations of the PEX19 binding site in TbPEX11 (second PEX19 BS, i.e., BS2) or ScPEX11 (single PEX19 BS) results in a mislocalization of the proteins to mitochondria. Trypanosomes contain multiple small glycosomes, but harbor a single mitochondrion (). We show that the extreme N-terminal region of TbPEX11 contains a cryptic N-terminal signal that directs PEX11 to the mitochondrion if its glycosomal transport is blocked.
2 Materials and methods
2.1 Cloning
Escherichia coli, yeast, and Trypanosoma expression plasmid constructs and cloning strategies are listed in Table 1, and oligonucleotide sequences are listed in Table 2. Point mutations in ScPEX11, TbPEX111-89aa, and the gene fragment deletions (TbPEX111-76aa and TbPEX11-GFP constructs) were generated by overlap extension PCR. Sequences of the constructs, mutations, and gene fragment deletions were verified for all constructs by automated Sanger sequencing.
TABLE 1
| Sl no. | Expression in | Construct | Primer pair | Restriction sites | Cloned in vector |
|---|---|---|---|---|---|
| 1 | E. coli | GST-TbPEX19 | RE2926 - RE7038 | BamHI/XhoI | pGEX4T-2 |
| 2 | E. coli | GST-HsPEX19 | pAH5 | ||
| 3 | S. cerevisiae | GAL4 AD-ScPEX14 | |||
| 4 | S. cerevisiae | GAL4 BD-ScPEX17167-199aa | |||
| 5 | S. cerevisiae | GAL4 AD-TbPEX191-285aa | RE3310 - RE3311 (pIA13, AG Erdmann) | SalI/NotI | pPC86 |
| 6 | S. cerevisiae | GAL4 BD-TbPEX111-218aa | RE7303 - RE7306 | SalI/NotI | pPC97 |
| 7 | S. cerevisiae | GAL4 BD-TbPEX111-89aa | RE7303 - RE7305 | SalI/NotI | pPC97 |
| 8 | S. cerevisiae | GAL4 BD-TbPEX1190-218aa | RE7304 - RE7306 | SalI/NotI | pPC97 |
| 9 | S. cerevisiae | GAL4 BD-TbPEX111-76aa | RE8882—RE8883 | Quick change PCR | pPC97 |
| 10 | S. cerevisiae | GAL4 BD-TbPEX111-89aa (S 25 D) | RE7713 - RE7714 | Quick change PCR | pPC97 |
| 11 | S. cerevisiae | GAL4 BD-TbPEX111-89aa (S 25 P) | RE7715 - RE7716 | Quick change PCR | pPC97 |
| 12 | S. cerevisiae | GAL4 BD-TbPEX111-89aa (L 31 P) | RE7717 - RE7718 | Quick change PCR | pPC97 |
| 13 | S. cerevisiae | GAL4 BD-TbPEX111-89aa (S 25 P, L 31 P) | RE7715 - RE7716, RE7717 - RE7718 | Quick change PCR | pPC97 |
| 14 | S. cerevisiae | GAL4 AD-HsPEX19 | RE7706 - RE7707 | SalI/NotI | pPC86 |
| 15 | S. cerevisiae | GAL4 BD-HsPEX111-73aa | RE7843 - RE7844 | SalI/NotI | pPC97 |
| 16 | S. cerevisiae | GAL4 BD-HsPEX111-73aa | RE7708 - RE7709 | SalI/NotI | pPC97 |
| 17 | S. cerevisiae | GAL4 BD-HsPEX111-74aa | RE7845 - RE7846 | SalI/NotI | pPC97 |
| 18 | S. cerevisiae | ScPEX11-GFP | |||
| 19 | S. cerevisiae | ScPEX11 (L 35 P)-GFP | RE8063 - RE8064 | Quick change PCR | pUG35 |
| 20 | T. brucei | TbPEX11-GFP | RE8070 - RE8071 | BstBI/BamHI | pGN1 |
| 21 | T. brucei | TbPEX11Δ13-35aa-GFP | RE8072 - RE8073 | Quick change PCR | pGN1 |
| 22 | T. brucei | TbPEX11Δ77-99aa-GFP | RE8074 - RE8075 | Quick change PCR | pGN1 |
| 23 | T. brucei | TbPEX111-90aa-GFP | RE7378 - RE7379 | ApaI/BamHI | pGN1 |
| 24 | T. brucei | TbPEX111-90aa-Δ13-35aa-GFP | RE8072 - RE8073 | Quick change PCR | pGN1 |
| 25 | T. brucei | TbPEX111-90aa-Δ2-11aa-GFP | RE8096 - RE7379 | BstBI/BamHI | pGN1 |
Strains and plasmids.
TABLE 2
| Primer | Sequence 5′to 3′ |
|---|---|
| RE2926 | GATCGGATCCATGTCTCATCCCGACAATGAC |
| RE3310 | GATCGTCGACGATGTCTCATCCCGACAATGAC |
| RE3311 | GATCGCGGCCGCCTACACTGATGGTTGCACATCG |
| RE7038 | CCGCTCGAGTTACACTGATGGTTGCACATCGGCAAGTCC |
| RE7303 | TGGACCGTCGACGATGTCTGAGTTCCAAAGGTTTGTT |
| RE7304 | AATATAGTCGACTAAGTTCCTCCGCGTGCTGTGC |
| RE7305 | AAGATAGCGGCCGCTTACAAGACCTCTTTCATGTTGAC |
| RE7306 | AATAAGCGGCCGCCTATTTGATCTTGTTCCAGTTCAA |
| RE7378 | AAGATAGGGCCCATGTCTGAGTTCCAAAGGTTTGTT |
| RE7379 | AAATGGATCCGATCCGCTTCCCTTCAAGACCTCTTTCATGTTGAC |
| RE7706 | AAGACGTCGACCATGGCCGCCGCTGAGGAAGGCTG |
| RE7707 | AAGACGCGGCCGCTCACATGATCAGACACTGTTCA |
| RE7708 | AAGATGTCGACAATGGACGCCTGGGTCCGCTTCAG |
| RE7709 | AAGACGCGGCCGCTTATCTTTTGGCTGACTCAAGG |
| RE7713 | GCCTTAAAGACACCATCAAATGCCTTTAGAATCTTGTCGCGGC |
| RE7714 | GCCGCGACAAGATTCTAAAGGCATTTGATGGTGTCTTTAAGGC |
| RE7715 | CTTAAAGACACCAGGAAATGCCTTTAGAATCTTGTCGCGG |
| RE7716 | CCGCGACAAGATTCTAAAGGCATTTCCTGGTGTCTTTAAG |
| RE7717 | GTGTCGAGGGAGCCAGGTGCCTTAAAGACAC |
| RE7718 | GTGTCTTTAAGGCACCTGGCTCCCTCGACAC |
| RE7843 | AGAAGTCGACAATGGACGCCTTCACCCGCTTCACC |
| RE7844 | AAGAGCGGCCGCTTACTGCTCAGTTGCCTGTATAG |
| RE7845 | AAGAAGTCGACAATGGCGTCGCTGAGCGGCCTGG |
| RE7846 | AAGAGCGGCCGCTTATTGCTTAGTGTAGACAAACA |
| RE8063 | CTGCTAAAAATCTTGCTGGATACTGCAGTAATCTGAGAACCTTTTCTCTGC |
| RE8064 | GCAGAGAAAAGGTTCTCAGATTACTGCAGTATCCAGCAAGATTTTTAGCAG |
| RE8070 | AAGAATTCGAAATGTCTGAGTTCCAAAGGTTTGTT |
| RE8071 | AAGACGGATCCGATTTGATCTTGTTCCAGTTCAA |
| RE8072 | TTCTTGAGACCTGTCAGAGCCGCTCAAG |
| RE8073 | GACAGGTCTCAAGAAGCTTAACAAACCTTTGG |
| RE8074 | TTCAGGATTATGTGCTCGGCGACAATG |
| RE8075 | GCACATAATCCTGAATGGCATTCTGC |
| RE8096 | AAGACTTCGAAATGGAGCAGACAGATGGCCGCGAC |
| RE8882 | TTCAGGATTAAGCGGCCGCTAAGTAAG |
| RE8883 | CCGCTTAATCCTGAATGGCATTCTGCATC |
Oligonucleotides.
2.2 Cell culture
2.2.1 Trypanosoma
Trypanosoma procyclic form (PCF) 29–13 cell line (co-expressing T7 RNAP and TetR) was used in this study. PCF cells were grown in SDM-79 medium supplemented with 10% FBS at 28°C (; ). PCF cultures were maintained at 1 × 106–30 × 106 cells/mL. Transfections were performed with NotI-linearized plasmid constructs (pGN1-TbPEX11 constructs), which was genomically integrated into the rRNA locus in the genome of cell line 29–13. Clones were selected using Blasticidin (10 μg/mL) as described previously ().
2.2.2 Yeast
S. cerevisiae wild-type strain BY4742 (for microscopy) and strain PCY2 (WT or Δpex19 for yeast two-hybrid assay) were grown in double dropout SD synthetic media as described in section 2.3 and 2.4.2. Yeast cells were transformed by the traditional Lithium-acetate method ().
2.2.3 Escherichia coli
Escherichia coli strain TOP10 was used for all plasmid amplifications and BL21 (DE3) strain was used for heterologous expression of recombinant GST-PEX19 fusion proteins. Liquid E. coli cultures were grown at 37°C under continuous shaking in LB medium containing the appropriate selective antibiotic (100 μg/mL Ampicillin).
2.3 Yeast two-hybrid analysis (Y2H)
Y2H studies were performed based on the Yeast protocols handbook (Clontech, Protocol No. PT3024-1, Version No. PR742227). Full length or various truncations of Trypanosoma or Human PEX11 were cloned in pPC97 vector containing GAL4-DNA Binding Domain (BD) and full-length Trypanosoma or human PEX19 were cloned in pPC86 vector containing GAL4-Activation domain (AD), as described in Table 1. Co-transformation of various two-hybrid plasmids i.e., BD and AD constructs were performed in WT PCY2 or Δpex19 PCY2 strain in case of HsPEX19-HsPEX11 constructs. The clones were selected on SD synthetic medium without tryptophan and leucine. A filter-based β-galactosidase assay and liquid culture assay using ONPG were performed in three replicates as described in the Yeast protocols handbook (Clontech).
2.4 Microscopy
2.4.1 Trypanosoma
Trypanosoma stable cell lines (Procyclic 29:13) encoding various tetracycline inducible PEX11-GFP constructs (full-length and mutants) were induced with 1 μg/mL tetracycline or treated with DMSO alone as negative control. Cells were sedimented and fixed by resuspension in 4% paraformaldehyde in PBS (phosphate-buffered saline, pH 7.4) at 4°C for 15 min. Fixed Trypanosoma cells were washed two times with PBS and stored at 4°C in a dark box. For imaging, fixed cells were immobilized on a glass slide (StarFrost 76 × 26 mm, Knittel Glass) pre-coated with 10% (v/v) of poly-L-lysine (Sigma-Aldrich) in water for 1 h at room temperature (RT). Further, the cell membranes were permeabilized with PBS containing 0.125% Triton X-100 and incubated for 10–15 min, followed by blocking with PBS containing 3% BSA, 0.25% Tween-20 for 1 h at RT. Rabbit α-Aldolase antibody (1:500 in blocking buffer) was used as glycosomal marker and incubated at RT for 1 h. Following 5 washes with PBS, anti-rabbit Alexa fluor 594 secondary antibodies (1:200 dilution) in PBS was applied and incubated for 30 min at RT in the dark. Further, the stained samples were washed, dried, and layered with anti-fading mounting medium, i.e., Mowiol with DAPI (4′,6-diamidino-2-phenylindole).
For mitochondrial staining, tetracycline-induced or uninduced (DMSO-treated) Trypanosoma cells were harvested and resuspended in the culture medium containing 75 nM MitoTracker® Deep Red and incubated for 5 min at 28°C. Following incubation, cells were washed with PBS twice and resuspended in the culture medium and further incubated for 30 min at 28°C. Subsequently, cells were fixed with 4% paraformaldehyde in PBS, and samples were prepared for microscopy as mentioned above.
Glycosome- or mitochondrion-stained cells were visualized and imaged with a Zeiss Elyra microscope and were analyzed using Zeiss Zen 3.2 software (blue edition). Both aldolase and MitoTracker which are markers for glycosome and mitochondrion respectively, are pseudo-colored to magenta for visualization.
2.4.2 Yeast
BY4742 yeast strain co-transformed with the plasmids encoding ScPEX11-GFP (WT () and L35 to P mutant, with the endogenous promoter) and DsRed-SKL (as a peroxisomal reporter ()) were grown overnight (16 h) with shaking in an SD synthetic medium without uracil and histidine. Next day the precultures were diluted to 0.1 OD600/mL and were incubated under shaking until the cell density reached 0.6–0.8 OD600/mL. After incubation, 1–2 mL cultures were harvested and washed with water. For mitochondrial staining, 5 mL of yeast cells, grown to a density of 0.6–0.8 OD600/mL, expressing the ScPEX11 constructs were stained with 150 nM MitoTracker™ Orange CMTMRos (Invitrogen) for 30 min with shaking in dark. Following incubation, 1–2 mL cultures were harvested and washed with water. All incubation steps were performed at 30°C. Yeast cells expressing various fluorescent proteins were directly visualized microscopically without fixation. Microscopy was performed with Carl Zeiss Microscope, using the Axiovision 4.6.3 software, and images were analyzed using Zen 3.2 (blue edition), a Carl Zeiss software. The DsRed-SKL, a peroxisomal reporter is pseudo-colored to magenta for visualization.
2.5 Peptide array
The immobilized peptides of 15-amino acids length, sequentially overlapping by 13 residues (2aa shift), representing the entire sequence of TbPEX11 or the N-terminal domains of three human PEX11 isoforms were synthesized on a cellulose membrane as described previously (; ). The peptide array was first washed with ethanol for 10 min with gentle shaking followed by three washes with TBS (50 mM Tris, 137 mM NaCl, 2.7 mM KCl, adjusted to pH 8) for 10 min each. Further, the peptide array was incubated with a blocking buffer (TBS +3% BSA +0.05% Tween-20) for 2 h at room temperature (RT). The purified recombinant proteins GST-TbPEX19, GST-HsPEX19, or GST alone (10 mL of 1 µM solution prepared in blocking buffer) were incubated with the arrays for 1 h at 4°C. Then, the arrays were washed three times for 10 min at RT with TBS, and subsequently incubated with the anti-GST monoclonal antibody (Sigma, 1:2000) at RT for 1 h. Followed by three washes with TBS (10 min each), a secondary antibody (Horseradish peroxidase-coupled anti-mouse IgGs, 1:5,000 in blocking buffer) was applied, and the array was further incubated for 1 h at RT. After three washes with TBS, the array was scanned with chemiluminescence substrate (WesternBright Sirius) using Azure sapphire biomolecular imager.
2.6 Protein expression and purification, in vitro pull-downs and AlphaScreen binding assay
2.6.1 Protein expression and purification
The expression plasmids pGEX4T2, pGEX4T2-TbPEX19 or pGEX4T1-HsPEX19, encoding for GST, GST-TbPEX19 or GST-HsPEX19, respectively, were transformed into BL21 (DE3) E. coli strain. Single colonies were inoculated in LB medium containing ampicillin and incubated overnight with shaking at 37°C. On the following day, the cultures were reinoculated with 0.1 OD600/mL and further incubated at 37°C with shaking, until the cell density reached 0.6 OD600/mL. Protein expression was induced with 1 mM IPTG for 4 h at 30°C. Harvested cell pellets were stored at −20°C before use. For protein purification, E. coli cell pellets were resuspended in PBS with protease inhibitors (5 μg/mL Antipain, 2 μg/mL Aprotinin, 0.35 μg/mL Bestatin, 6 μg/mL Chymostatin, 2.5 μg/mL Leupeptin, 1 μg/mL Pepstatin, 0.1 mM PMSF, 25 μg/mL DNAse and 1 mM DTT). Cells were disrupted using EmulsiFlex and unbroken cells were removed by centrifugation at 4,500 rpm for 15 min (rotor SX4400, Beckman Coulter). The resulting supernatant (SN1) was subjected to a high-speed centrifugation at 14,000 rpm for 1 h (rotor SS-34, Thermo Scientific), which yielded supernatant 2 (SN2), a soluble fraction that included overexpressed proteins. Proteins were purified by affinity chromatography using Glutathione Agarose 4B beads (Macherey-Nagel). To this end, SN2 was incubated with the pre-equilibrated glutathione agarose beads for 2 h in a tube rotator. After collection of the flow-through, using a gravity flow column, the protein-bound beads were washed five times with PBS. Proteins were eluted with 10 mM reduced glutathione in 50 mM Tris-Cl (pH 8). The buffer of the eluted protein was exchanged to PBS using Amicon centrifugation tubes with molecular weight cut-off (MWCO) 10 kDa. The concentration of the proteins was determined by the Bradford method (Thermo, Coomassie Plus assay kit), and protein aliquots were stored at—80°C. All the purification steps were performed at 4°C.
2.6.2 In vitro pull-down
20 µL bed volume Glutathione Agarose 4B beads (Macherey-Nagel) were incubated with 200 µg of recombinantly purified GST and GST-TbPEX19 proteins in separate tubes for 2 h at 4°C with gentle rotation. Following incubation, beads were washed with PBS to remove unbound proteins. Subsequently, 25 µg of C-terminally His6-tagged synthetic peptides of crude grade, containing the corresponding TbPEX19 binding regions in TbPEX11 (BS1-BS3) were loaded to the respective tubes and were incubated for 2 h at 4°C with gentle rotation to allow binding of the peptides to GST-TbPEX19 or control GST. Following washes with PBS, the bound proteins/peptides were eluted with 50 µL 10 mM reduced glutathione in 50 mM Tris (pH 8). The eluted samples were analyzed by SDS-PAGE followed by Coomassie staining and immunoblotting. The sequences of the TbPEX11 peptides used for the pull-down are as follows, BS1: QTDGRDKILKAFSGVFKALGSLD-GS-His6, BS2: CRAKGKVNMKEVLKFLRVLCNFL-GS-His6 and BS3: VLDVVALYGALQKRASDPATS-GS-His6.
2.6.3 AlphaScreen binding assay
N-terminal GST tagged TbPEX19 and TbPEX11 peptides with C-/N-terminal His6 were used for the interaction study with the AlphaScreen system. The final reaction volume used for the study was 25 μL, which consist of 5 μL of each protein solution (30 nM for PEX19 and 300 nM of PEX11 peptides), 5 μL of buffer, and 5 μL of solution for each of the donor and acceptor beads (5 μg/mL). The above solutions were prepared in reaction buffer [0.5% BSA v/v, PBS (pH7.4)] on the day of the assay. Compounds were incubated with the proteins for 30 min at room temperature (RT). 5 μL of AlphaScreen Nickel-chelate acceptor beads (cat. no. 6760619C, PerkinElmer®) were added to the above mixture following 15 min incubation at RT. 5 μL AlphaScreen Glutathione donor beads (cat. no. 6765300, PerkinElmer®) were added to the mixture. The complete 25 μL reaction solutions were incubated for 45 min at RT in the dark, and Alpha signals were captured with Cytation 5 plate reader (BioTek®) with the gain value set at 180. All above concentrations mentioned for the AlphaScreen assays were final concentrations unless otherwise stated. The sequences of the TbPEX11 peptides used for the AlphaScreen assay are as follows, BS1: QTDGRDKILKAFSGVFKALGSLD-GS-His6, His6-GS-QTDGRDKILKAFSGVFKALGSLD and BS2: CRAKGKVNMKEVLKFLRVLCNFL-GS-His6. The binding assay were performed in three biological replicates, with 3 technical replicates each.
2.7 Immunoblotting
Proteins separated by SDS-PAGE were transferred on a nitrocellulose membrane with a pore size of 0.45 μm (Amersham Biosciences). Blotting was performed by using the MiniProtean III cell (BioRad) with blot transfer buffer (Dunn carbonate buffer) for 1 h with a constant current of 300 mA per chamber. Further, the membrane was blocked for 1 h at room temperature (RT), under constant swirling with 3% BSA in blot washing buffer (TBS with 0.05% Tween-20) to avoid nonspecific binding of antibodies. Then, the membrane was washed three times for 5 min at RT, and subsequently incubated with the primary antibodies in blot washing buffer at 4°C overnight. Following primary antibodies were used in this study: mouse anti-GFP (Sigma, 1:2,000), anti-GAL4 AD/-BD (Santa Cruz Biotechnology, 1:1,000) or anti-His6 (Invitrogen, 1:2,000); rabbit anti-Trypanosoma Aldolase (1:20,000) or Enolase (1:20,000), and anti-Porin (S. cerevisiae, 1:10,000). After three washing steps, the corresponding secondary antibodies i.e., goat anti-rabbit IRDye 680 or goat anti-mouse IRDye 800CW (LI-COR Biosciences, both 1:15,000 in blot wash buffer) were applied, and the membrane was further incubated for 30 min at RT in the dark. Following three washes, immunoblots were scanned using the Li-Cor Odyssey 9120 Infrared Imaging System.
2.8 Statistical analysis
Microscopic data was collected from two independent S. cerevisiae or T. brucei cultures. Images were quantified using Pearson’s correlation coefficient, which was calculated with colocalization tool of Zen 3.6 pro (blue edition). Statistical significances for colocalization studies were calculated using a one-way ANOVA (mixed) by Dunnett’s multiple comparisons test (comparison with WT control) with each row representing matched or repeated measures. Statistical analysis for AlphaScreen results was done using two-way ANOVA with Bonferroni’s multiple comparison test (comparison with respective controls) with the values obtained from three independent biological replicates, each with three technical replicates.
3 Results
3.1 Identification and validation of PEX19 binding sites in Trypanosoma brucei PEX11
PEX19 acts as a cytosolic chaperone and receptor for the import of newly synthesized class 1 peroxisomal membrane proteins (PMPs), except the class II PMP i.e., PEX3, which can be imported independent of PEX19 (; ). PMPs contain multiple PEX19 binding sites, which are well characterized in yeast and humans. This includes the most abundant yeast PMP Pex11p and related PEX11-family proteins Pex25p and Pex27p (; ). In trypanosomatid parasites, PEX19 binding sites have been identified in various glycosomal membrane proteins as well as parasite specific PEX11 family proteins GIM5A/B (). However, the PEX19-binding sites (-BS) in parasite PEX11 remained uncharacterized. To identify these binding sites, we obtained synthetic peptide arrays, containing consecutive 15-amino acid peptides with two amino acid shifts, representing the entire sequence of TbPEX11. Affinity purified recombinant GST-TbPEX19 (Purification profile described in Supplementary Figure S1), or GST alone were incubated with the arrays and bound proteins were immuno-detected using monoclonal anti-GST antibodies. Immunodetection of at least three consecutive spots were considered as potential PEX19 binding sites (). Comparison of control and test peptide arrays revealed the presence of three potential PEX19 binding sites (BS1-BS3) in TbPEX11 (Figure 1). The topological prediction of transmembrane domains (TMDs) using Phobius webserver () indicates that TbPEX11 contains four TMDs and an N-terminal extension of about 90 amino acids to the cytosol (Supplementary Figure S2). The first PEX19 binding site (BS1) is present close to the N-terminus of TbPEX11 between amino acid (aa) residues 13–35, the second and third PEX19 binding sites are located between aa77-99 and aa139-159, respectively, in proximity of the first and second predicted transmembrane domains (Figure 1C). Both N- and C-termini of TbPEX11 face the cytosol (), which implies that the BS1 would remain exposed to the cytosol even after targeting and insertion of TbPEX11 into the glycosomal membrane.
FIGURE 1
PEX19 binding motifs are conserved between peroxisomal proteins of yeast or mammals and trypanosomal glycosomal proteins (). Probing of the TbPEX11 peptide array with GST-tagged recombinant human PEX19 also revealed a similar binding pattern (Supplementary Figure S3) as observed with TbPEX19 (Figure 1). This further demonstrates the conservation of PEX19-BSs, which can be recognized by PEX19 from different organisms.
Binding of TbPEX19 to the newly identified regions in TbPEX11 were further investigated by yeast two-hybrid (Y2H) analysis and in vitro binding assays using pull-down and AlphaScreen. For the Y2H assay, GAL4-AD fusion of TbPEX19 was used since the corresponding GAL4-BD fusions showed autoactivation (not shown). In addition to this, the corresponding GAL4-BD fused PEX11 constructs did not result in the auto activation when tested with GAL4-AD alone (not shown). Various TbPEX11 constructs fused to GAL4-BD were tested for interaction with TbPEX19 (Figure 2A). Full length TbPEX11 showed only a very weak interaction with TbPEX19. This could be due to the presence of several predicted transmembrane domains in TbPEX11, which may hinder the translocation into the nucleus and activation of GAL-promoter. However, the N-terminal fragment of TbPEX111-89aa that has been predicted to be soluble (Supplementary Figure S2) showed a clear and strong interaction with the full length TbPEX19, in both plate-based (sensitive) and liquid Y2H assays (quantitative) (Figure 2A). Construct that lacks the N-terminal domain but contains BS3 (TbPEX1190-218aa) did not interact with TbPEX19. TbPEX111-89 contains BS1 as well as partial BS2. We also tested a shorter construct that contains only BS1 (TbPEX111-76), which still showed a strong interaction with TbPEX19. Immunoblotting confirmed that all constructs are expressed in yeast at correct molecular weights (Figure 2B). Furthermore, we opted to introduce two mutations in Trypanosoma PEX11. The first mutation replaced serine 25, which is in the TbPEX19 BS1 region, by aspartate to mimic phosphorylation (based on the post-translational modifications database). For the second mutation, we referred to a study in baker’s yeast, which showed that replacing leucine at position 35 by proline results in the loss of interaction (). We aligned the sequence with ScPEX11 and chose the closest leucine residue (position 31) for replacement by proline. Mutation of serine25 to aspartate i.e., phospho-mimicking did not affect the interaction, whereas mutation of serine25 or leucine31 individually and together to proline within BS1 in TbPEX111-89 led to a reduced or complete abolishment of the interaction with TbPEX19 (Supplementary Figure S4). Based on the peptide blot and the Y2H studies, it can be concluded that BS1 is a bona fide PEX19 binding motif.
FIGURE 2
As an alternative, we obtained C-terminally His6-tagged synthetic peptides of TbPEX11 corresponding to the three putative PEX19 binding sites. Affinity pull-down was performed with GST-TbPEX19 or GST alone as negative control, which were bound to the glutathione affinity beads. Glutathione eluates of the in vitro pull-downs were analyzed by Coomassie staining as well as immunoblotting using anti-His6 tag antibodies (Figure 2C; full profile of the pull-downs is shown in Supplementary Figure S5). The analysis shows that the synthetic peptide corresponding to BS2 (running at ∼10 kDa) is efficiently retained with TbPEX19 but not with GST alone. Similar binding of the BS2 representing peptide of TbPEX11 was also observed with recombinant human GST-PEX19 (not shown). The synthetic peptides corresponding to BS1 and BS3 (both running at ∼10 kDa) did not bind to recombinant GST-TbPEX19 in this assay. The third putative PEX19 binding site (BS3) in TbPEX11 that was identified in the peptide array analysis (Figure 1) could not be further validated by the methods employed here and was not considered further.
Finally, we analyzed the interaction of BS1 and BS2 with TbPEX19 with the more sensitive AlphaScreen assay. This assay was performed using C-terminally His6-tagged peptides that represent the TbPEX11 binding sites with GST-TbPEX19 or GST as negative control (Supplementary Figure S6). Again, the BS2 showed a clear interaction with TbPEX19, while the BS1 did not interact. As the interacting BS1 containing region was N-terminally tagged in the Y2H assay (Figure 2A), we considered that the orientation of the tag might have an influence and therefore analyzed the interaction of an N-terminally tagged BS1-peptide, which indeed showed a significant interaction with TbPEX19 (Supplementary Figure S6). Taken together this study identified two PEX19 binding sites in TbPEX11 (BS1 and BS2).
3.2 Role of PEX19 binding sites in glycosomal targeting of TbPEX11
We performed immunofluorescence microscopy analysis to assess the relevance of the newly identified PEX19 binding sites for the topogenesis of TbPEX11. Tetracycline inducible stable cell lines of Trypanosoma were generated, which express C-terminally GFP-tagged full-length TbPEX11 and variants lacking either BS1 or BS2. Glycosomal localization of the constructs was investigated by analysis of colocalization of the fluorescent GFP-fusions of TbPEX11 with the glycosomal marker enzyme aldolase, which was monitored by immunofluorescence microscopy. Overexpressed TbPEX11WT-GFP colocalized with the glycosomal marker, indicative for its glycosomal localization (Figure 3A, upper panel). However, frequently glycosomes appeared to cluster, confirming an earlier study reporting that overexpression of TbPEX11 results in clustering of glycosomes in bloodstream form of T. brucei (). The GFP fluorescence of cells expressing both truncated TbPEX11 variants was much weaker in comparison to the wild-type protein and clustering of glycosomes was not seen. This is explained by the decreased steady-state concentration of both truncated proteins, which is much lower in comparison to the full-length TbPEX11 as indicated by the corresponding immunoblots. (Figure 3D). However, the fluorescence was bright enough to allow investigation of their subcellular localization. TbPEX11 lacking BS1 (TbPEX11△BS1-GFP) still showed a partial glycosomal localization (Figure 3A, Middle panel), while the TbPEX11 variant lacking BS2 (TbPEX11△BS2-GFP) was mislocalized, as indicated by the lacking colocalization with the glycosomal marker (Figure 3A, lower panel). Taken together this result demonstrated that deficiency in either BS1 or BS2 affects the steady-state concentration of TbPEX11. Thus, binding of PEX19 to either of these sites might stabilize the protein. This is in agreement with studies in yeast, which showed that various PMPs, including PEX11, are unstable and their steady state levels are significantly reduced in PEX19-or PEX3-deficient cells (). In the absence of BS1, the remaining small amount of TbPEX11 is still directed to glycosomes, while in the absence of BS2, PEX11 is mistargeted, indicating that BS2 is essential for glycosomal targeting of TbPEX11.
FIGURE 3
In yeast, PEX11 mislocalizes to mitochondria in cells lacking peroxisomal membranes (
Multiple sequence alignment of the N-terminal region comprising BS1 of Trypanosoma, yeast, human, and plant PEX11 family proteins or isoforms indicates a high degree of sequence conservation, suggesting that the region corresponding to trypanosomal BS1 is conserved among PEX11 species (Figure 4A). To investigate the capacity of this region of human PEX11 proteins for PEX19 binding, we obtained synthetic peptide array of N-terminal soluble domains of all three human PEX11 isoforms (15mer peptides with 2-amino acids shifts). The arrays were probed with GST alone as a negative control, which showed little or no background (Figure 4B, upper panel). Probing the array with GST-HsPEX19 revealed that the peptides from PEX11γ did not bind PEX19, while PEX11α and PEX11β do contain potential PEX19-BS (Figure 4B, lower panel). To validate the interactions, Y2H analysis was performed to investigate the interaction of N-terminal domains of PEX11 isoforms and human PEX19 (Figure 4C). An interaction was seen only with PEX11β, in both the plate-based and the liquid assay. Immunoblot analysis of lysates of yeast cell used in Y2H shows that PEX11α and β were expressed, but not PEX11γ (Figure 4D). As PEX11γ was not expressed, no conclusion can be drawn from the negative result of the two-hybrid study. However, the results are clear in that PEX11β indeed does contain a PEX19 binding site in the region that corresponds to trypanosomal BS1.
FIGURE 4

The N-terminal PEX19 binding site in PEX11 is conserved among species. (A) Multiple sequence alignment of N-terminal sequences of PEX11 proteins from parasites, baker’s yeast, humans, and plants shows a high degree of conservation. The N-terminal PEX19 binding site (BS1) identified in Trypanosoma brucei is indicated by a black dotted box. The known PEX19 binding site from yeast and the newly identified PEX19 binding sites in humans are also indicated by black dotted boxes. (B) Identification of N-terminal PEX19 binding site in the human members of the PEX11 family. Synthetic 15-mer peptides with 2-amino acids shift of the N-terminal protein sequence of HsPEX11 (α, β and γ) were synthesized on cellulose membrane and probed with GST as a negative control (upper panel) or GST-HsPEX19 (lower panel). The bound analyte was immunodetected using primary antibodies against GST and horseradish peroxidase coupled secondary antibody. The signal was monitored using chemiluminescence. Binding regions in HsPEX11 (α and β) showed clear interaction with HsPEX19 (red boxes). (C) Validation of identified binding sites by Yeast two-hybrid analysis using Δpex19 PCY2 strain. Scheme of the cotransformed HsPEX19 and HsPEX11 (α, β and γ) N-terminal constructs is shown on the left. Colony lift filter assay (I) and liquid ONPG assay (II) were performed using full-length HsPEX19 and different constructs of HsPEX11 fused to GAL4-AD and -BD as indicated. The interaction of yeast PEX14-PEX17 served as a positive control. Both assays were performed in three replicates and the β-galactosidase activity units shown are an average of the technical replicates with three different clones. Error bars represents mean with standard deviations. Of the three members of the PEX11-family only the N-terminal fragment of HsPEX11β showed a clear interaction with full-length HsPEX19. (D) Expression of the GAL4-AD and -BD fused proteins were tested by immunoblotting using GAL4-AD and -BD with monoclonal antibodies. No expression of Gal BD-HsPEX11γ N-terminal fragment was detected.
In yeast, ScPEX11 contains only one PEX19 binding site, spanning amino acids 27–41 (
FIGURE 5

The N-terminal binding site for PEX19 is essential for peroxisomal localization of ScPEX11. Plasmids expressing ScPEX11-GFP (wildtype and L35P-mutant) or the peroxisomal marker protein DsRed-SKL were cotransformed in the BY4742 yeast strain. (A) Clones expressing GFP fusion proteins and the peroxisomal marker DsRed-SKL were grown on plates and visualized by fluorescence microscopy. Merged images reveal peroxisomal colocalization of ScPEX11-GFP (wildtype) with DsRed-SKL (pseudo-colored to magenta), indicative for its peroxisomal localization. In contrast, the L35P exchange that is known to block PEX19 binding site result in mislocalization of ScPEX11. (B)ScPEX11-GFP with mutation L35P mislocalizes to mitochondria as demonstrated by its colocalization with MitoTracker (pseudo-colored to magenta). DIC–Differential Interference Contrast, Scale bar—5 μm. (C) Quantification of the colocalization of ScPEX11-GFP to peroxisomes (left) or mitochondria (right). The Pearson’s coefficient of colocalization to respective organelle is shown. Dots within the violin plot indicates individual Pearson correlation coefficient data points and the central line represents the median. Statistical significances were calculated by one-way ANOVA, with Dunnett’s multiple comparisons test (n ≥ 35 cells). ****, p < 0.0001; ***, p = 0.0003; ns, not significant. (D) Expression of ScPEX11-GFP (wildtype and L35P mutant) was tested by immunoblotting with anti-GFP antibody, which revealed that the steady-state concentration of the L35P is much lower than that of the corresponding wild-type protein. Porin served as the loading control.
The data show that PEX11 from Trypanosoma and yeast as well as PEX11β from humans contain a conserved N-terminal region that can bind PEX19. This region, corresponding to BS1 in Trypanosoma, is required to maintain the steady-state concentration of PEX11 in all studied species, and at least for yeast, it is shown that it is also required for efficient targeting of PEX11 to peroxisomes.
3.3 Cryptic N-terminal targeting signal of trypanosomal PEX11
In the absence of PEX19, PMPs are mislocalized to the cytosol and rapidly degraded, or mislocalized to other membranes. For example, PEX3 localizes to the endoplasmic reticulum (
FIGURE 6

Cryptic signal at the N-terminus causes mitochondrial mislocalization of TbPEX11. (A) Upper panel: Prediction of two overlapping putative TOM20 motifs with positively charged amphiphilicity within the N-terminal region TbPEX11 and partially overlapping with the PEX19 binding site region (red dotted box). The residue highlighted in red indicates the presence of a mitochondrial processing peptidase (MPP) cleavage site. The presence of a predicted TOM20 recognition motif and positively charged amphiphilic region with MPP cleavage site were determined by Mitofates webtool (https://mitf.cbrc.pj.aist.go.jp/MitoFates/cgi-bin/top.cgi). Lower panel: Multiple sequence alignment of N-terminal sequences of PEX11 proteins from parasites, yeast, humans, and plants indicates the presence of conserved TOM20 motifs with positively charged (red) residues encased by hydrophobic (blue) amino acid residues. (B) Subcellular localization of the N-terminal domain of TbPEX11 (1–90aa) fused to GFP with and without deletion of the PEX19-binding site 1 (Δ13-35aa) or deletion of a N-terminal putative TOM20 binding motif (Δ2-11aa) by fluorescence and immunofluorescence microscopy. The non-truncated fusion with and without PEX19 binding site 1 (BS1) did not co-localize with the glycosomal marker aldolase but was targeted to mitochondrion as shown below (upper and middle panel). The TbPEX11-GFP lacking the TOM20 motif did mislocalize to the cytosol as indicated by the overall cell labelling (lower panel). (C) The non-truncated fusion with and without PEX19 binding site 1 (BS1) localized to the mitochondrion, demonstrated by their colocalization with MitoTracker (upper and middle panel, respectively). The glycosomal marker aldolase (pseudo-colored to magenta) was labelled with the corresponding antibody, nuclei and kinetoplasts were stained with DAPI, and mitochondrion was visualized by MitoTracker (pseudo-colored to magenta). Scale bar—5 μm. (D) Quantification of the colocalization to glycosomes (left) or the mitochondrion (right). The Pearson’s coefficient of colocalization to respective organelle is shown. Dots within the violin plot indicate individual Pearson correlation coefficient data points and the central line represents the median. Statistical significances were calculated by one-way ANOVA, with Dunnett’s multiple comparisons test (n ≥ 35 cells). ****, p < 0.0001; ***, p = 0.0001; *, p = 0.0262; ns, not significant.
4 Discussion
Here we show that the glycosomal membrane protein TbPEX11 contains two PEX19 binding sites in its N-terminal region, as shown by peptide array analysis, yeast two-hybrid studies, pull-down experiments, and AlphaScreen assays. PEX19 is a peroxisomal membrane protein (PMP) receptor and chaperone that stabilizes its cargo proteins and targets them to peroxisomes (
Eukaryotic organisms contain multiple proteins belonging to the PEX11 family. In yeast, Pex11p contains a single PEX19-BS near its N-terminus, while in the other ScPEX11-family members, Pex25p and Pex27p, binding of PEX19 occurs far distal from the N-terminus (
Our data indicate that the N-terminal binding site (BS1) for PEX19 is conserved among TbPEX11 orthologues but not in PEX11-family member GIM5/B of Trypanosoma or Leishmania (
In the absence of peroxisomes, many PMPs are unstable and degraded or mistargeted to other organelles such as ER and mitochondria. This is seen in yeast as well as in human cells derived from patients suffering from a Peroxisome Biogenesis Disorder (PBD) (
4.1 What could be the role of a mitochondrial targeting signal of PEX11?
In mature glycosomes/peroxisomes of the wild type cells, TbPEX11-NTD is exposed to the cytosol. In this case, the cryptic N-terminal signals may be masked by the oligomerization of PEX11. However, in newly formed glycosomes, which are importing PEX11, these signals may be still accessible to interact with the mitochondrial TOM machinery, and this may mediate glycosome-mitochondrion membrane contact site (MCS). Accordingly, association of ScPEX11 with the mitochondrial TOM complex has been seen in two studies, i) 37-fold enrichment of ScPEX11 in the SILAC based interactome of yeast TOM22 (
We do not yet know whether the newly identified cryptic mitochondrial targeting signal of TbPEX11 is of functional relevance. However, peroxisomes are not only metabolically linked to mitochondria but also share components of their division machinery (
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.
Author contributions
CK, VK, and RE conceived and planned the experiments. CK carried out the experiments. NS and KW contributed to the super-resolution fluorescence microscopy. BT performed the AlphaScreen assay. MJ synthesized the peptide array. CK, VK, and RE wrote the manuscript with support from WS. VK and RE supervised the project. All authors contributed to the article and approved the submitted version.
Funding
This project work has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 812968—PerICo (to CK, and RE). The work was supported by DFG grant FOR1905 to RE.
Acknowledgments
We thank Paul Michels for kindly providing various antibodies and Wolfgang Girzalsky for critical reading of the manuscript. We acknowledge support by the Open Access Publication Funds of the Ruhr-Universität Bochum.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2023.1213761/full#supplementary-material
References
1
AbeI.FujikiY. (1998a). cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. Biochem. Biophys. Res. Commun.252 (2), 529–533. 10.1006/bbrc.1998.9684
2
AbeI.OkumotoK.TamuraS.FujikiY. (1998b). Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett.431 (3), 468–472. 10.1016/s0014-5793(98)00815-1
3
AgrawalG.SubramaniS. (2016). De novo peroxisome biogenesis: evolving concepts and conundrums. Biochim. Biophys. Acta1863 (5), 892–901. 10.1016/j.bbamcr.2015.09.014
4
AlbertiniM.RehlingP.ErdmannR.GirzalskyW.KielJ. A.VeenhuisM.et al (1997). Pex14p, a peroxisomal membrane protein binding both receptors of the two PTS-dependent import pathways. Cell89 (1), 83–92. 10.1016/s0092-8674(00)80185-3
5
AntonM.PassreiterM.LayD.ThaiT. P.GorgasK.JustW. W. (2000). ARF- and coatomer-mediated peroxisomal vesiculation. Cell Biochem. Biophys.32 (1), 27–36. 10.1385/cbb:32:1-3:27
6
BreidenbachR. W.BeeversH. (1967). Association of the glyoxylate cycle enzymes in a novel subcellular particle from castor bean endosperm. Biochem. Biophys. Res. Commun.27 (4), 462–469. 10.1016/s0006-291x(67)80007-x
7
BackesS.HessS.BoosF.WoellhafM. W.GodelS.JungM.et al (2018). Tom70 enhances mitochondrial preprotein import efficiency by binding to internal targeting sequences. J. Cell Biol.217 (4), 1369–1382. 10.1083/jcb.201708044
8
BaerendsR. J.FaberK. N.KielJ. A.van der KleiI. J.HarderW.VeenhuisM. (2000). Sorting and function of peroxisomal membrane proteins. FEMS Microbiol. Rev.24 (3), 291–301. 10.1111/j.1574-6976.2000.tb00543.x
9
BanerjeeS. K.KesslerP. S.SaveriaT.ParsonsM. (2005). Identification of trypanosomatid PEX19: functional characterization reveals impact on cell growth and glycosome size and number. Mol. Biochem. Parasitol.142 (1), 47–55. 10.1016/j.molbiopara.2005.03.008
10
BonekampN. A.GrilleS.CardosoM. J.AlmeidaM.ArosoM.GomesS.et al (2013). Self-interaction of human Pex11pβ during peroxisomal growth and division. PLoS One8 (1), e53424. 10.1371/journal.pone.0053424
11
BoutoujaF.StiehmC. M.MastalskiT.BrinkmeierR.ReidickC.El MagraouiF.et al (2019). Vps10-mediated targeting of Pep4 determines the activity of the vacuole in a substrate-dependent manner. Sci. Rep.9 (1), 10557. 10.1038/s41598-019-47184-7
12
BrunR.Schonenberger (1979). Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. Acta Trop.36 (3), 289–292.
13
BykovY. S.FlohrT.BoosF.ZungN.HerrmannJ. M.SchuldinerM. (2022). Widespread use of unconventional targeting signals in mitochondrial ribosome proteins. EMBO J.41 (1), e109519. 10.15252/embj.2021109519
14
De DuveC.BaudhuinP. (1966). Peroxisomes (microbodies and related particles). Physiol. Rev.46 (2), 323–357. 10.1152/physrev.1966.46.2.323
15
DelilleH. K.AgricolaB.GuimaraesS. C.BortaH.LuersG. H.FransenM.et al (2010). Pex11pbeta-mediated growth and division of mammalian peroxisomes follows a maturation pathway. J. Cell Sci.123 (16), 2750–2762. 10.1242/jcs.062109
16
EckertJ. H.JohnssonN. (2003). Pex10p links the ubiquitin conjugating enzyme Pex4p to the protein import machinery of the peroxisome. J. Cell Sci.116 (17), 3623–3634. 10.1242/jcs.00678
17
Eisenberg-BordM.ZungN.ColladoJ.DrweshL.FenechE. J.FadelA.et al (2021). Cnm1 mediates nucleus-mitochondria contact site formation in response to phospholipid levels. J. Cell Biol.220 (11), e202104100. 10.1083/jcb.202104100
18
ErdmannR.BlobelG. (1995). Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p. J. Cell Biol.128 (4), 509–523. 10.1083/jcb.128.4.509
19
ErdmannR.SchliebsW. (2005). Peroxisomal matrix protein import: the transient pore model. Nat. Rev. Mol. Cell Biol.6 (9), 738–742. 10.1038/nrm1710
20
EspositoM.Hermann-Le DenmatS.DelahoddeA. (2019). Contribution of ERMES subunits to mature peroxisome abundance. PLoS One14 (3), e0214287. 10.1371/journal.pone.0214287
21
FaberK. N.Keizer-GunninkI.PluimD.HarderW.AbG.VeenhuisM. (1995). The N-terminus of amine oxidase of Hansenula polymorpha contains a peroxisomal targeting signal. FEBS Lett.357 (2), 115–120. 10.1016/0014-5793(94)01317-t
22
FukasawaY.TsujiJ.FuS. C.TomiiK.HortonP.ImaiK. (2015). MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites. Mol. Cell Proteomics14 (4), 1113–1126. 10.1074/mcp.M114.043083
23
GallandN.de WalqueS.VonckenF. G.VerlindeC. L.MichelsP. A. (2010). An internal sequence targets Trypanosoma brucei triosephosphate isomerase to glycosomes. Mol. Biochem. Parasitol.171 (1), 45–49. 10.1016/j.molbiopara.2010.01.002
24
GaoY.SkowyraM. L.FengP.RapoportT. A. (2022). Protein import into peroxisomes occurs through a nuclear pore-like phase. Science378 (6625), eadf3971. 10.1126/science.adf3971
25
GhaediK.TamuraS.OkumotoK.MatsuzonoY.FujikiY. (2000). The peroxin pex3p initiates membrane assembly in peroxisome biogenesis. Mol. Biol. Cell11 (6), 2085–2102. 10.1091/mbc.11.6.2085
26
GietzR. D.WoodsR. A. (2002). Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol.350, 87–96. 10.1016/s0076-6879(02)50957-5
27
GirzalskyW.HoffmannL. S.SchemenewitzA.NolteA.KunauW. H.ErdmannR. (2006). Pex19p-dependent targeting of Pex17p, a peripheral component of the peroxisomal protein import machinery. J. Biol. Chem.281 (28), 19417–19425. 10.1074/jbc.M603344200
28
GoldmanB. M.BlobelG. (1978). Biogenesis of peroxisomes: intracellular site of synthesis of catalase and uricase. Proc. Natl. Acad. Sci. U. S. A.75 (10), 5066–5070. 10.1073/pnas.75.10.5066
29
GouldS. J.KellerG. A.HoskenN.WilkinsonJ.SubramaniS. (1989). A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol.108 (5), 1657–1664. 10.1083/jcb.108.5.1657
30
HalbachA.LandgrafC.LorenzenS.RosenkranzK.Volkmer-EngertR.ErdmannR.et al (2006). Targeting of the tail-anchored peroxisomal membrane proteins PEX26 and PEX15 occurs through C-terminal PEX19-binding sites. J. Cell Sci.119 (12), 2508–2517. 10.1242/jcs.02979
31
HalbachA.LorenzenS.LandgrafC.Volkmer-EngertR.ErdmannR.RottensteinerH. (2005). Function of the PEX19-binding site of human adrenoleukodystrophy protein as targeting motif in man and yeast. PMP targeting is evolutionarily conserved. J. Biol. Chem.280 (22), 21176–21182. 10.1074/jbc.M501750200
32
HasanS.PlattaH. W.ErdmannR. (2013). Import of proteins into the peroxisomal matrix. Front. Physiol.4, 261. 10.3389/fphys.2013.00261
33
HettemaE. H.GirzalskyW.van Den BergM.ErdmannR.DistelB. (2000). Saccharomyces cerevisiae pex3p and pex19p are required for proper localization and stability of peroxisomal membrane proteins. EMBO J.19 (2), 223–233. 10.1093/emboj/19.2.223
34
HilpertK.WinklerD. F.HancockR. E. (2007). Peptide arrays on cellulose support: sPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat. Protoc.2 (6), 1333–1349. 10.1038/nprot.2007.160
35
HoepfnerD.SchildknegtD.BraakmanI.PhilippsenP.TabakH. F. (2005). Contribution of the endoplasmic reticulum to peroxisome formation. Cell122 (1), 85–95. 10.1016/j.cell.2005.04.025
36
IslingerM.LiK. W.SeitzJ.VolklA.LuersG. H. (2009). Hitchhiking of Cu/Zn superoxide dismutase to peroxisomes--evidence for a natural piggyback import mechanism in mammals. Traffic10 (11), 1711–1721. 10.1111/j.1600-0854.2009.00966.x
37
JansenR. L. M.van den NoortM.KrikkenA. M.BibiC.BohmA.SchuldinerM.et al (2023). Novel targeting assay uncovers targeting information within peroxisomal ABC transporter Pxa1. Biochim. Biophys. Acta Mol. Cell Res.1870 (5), 119471. 10.1016/j.bbamcr.2023.119471
38
JonesJ. M.MorrellJ. C.GouldS. J. (2004). PEX19 is a predominantly cytosolic chaperone and import receptor for class 1 peroxisomal membrane proteins. J. Cell Biol.164 (1), 57–67. 10.1083/jcb.200304111
39
KalelV. C.ErdmannR. (2018). Unraveling of the structure and function of peroxisomal protein import machineries. Subcell. Biochem.89, 299–321. 10.1007/978-981-13-2233-4_13
40
KalelV. C.SchliebsW.ErdmannR. (2015). Identification and functional characterization of Trypanosoma brucei peroxin 16. Biochim. Biophys. Acta1853 (10), 2326–2337. 10.1016/j.bbamcr.2015.05.024
41
KallL.KroghA.SonnhammerE. L. (2007). Advantages of combined transmembrane topology and signal peptide prediction--the Phobius web server. Nucleic Acids Res.35, W429–W432. Web Server issue). 10.1093/nar/gkm256
42
KamoshitaM.KumarR.AnteghiniM.KunzeM.IslingerM.Martins Dos SantosV.et al (2022). Insights into the peroxisomal protein inventory of zebrafish. Front. Physiol.13, 822509. 10.3389/fphys.2022.822509
43
KochJ.PranjicK.HuberA.EllingerA.HartigA.KraglerF.et al (2010). PEX11 family members are membrane elongation factors that coordinate peroxisome proliferation and maintenance. J. Cell Sci.123 (19), 3389–3400. 10.1242/jcs.064907
44
KrishnaC. K.FrankeL.ErdmannR.KalelV. C. (2023). “Isolation of glycosomes from trypanosoma brucei,” in Peroxisomes: Methods and protocols. Editor SchraderM. (New York, NY: Springer US), 33–45.
45
KunovaN.HavalovaH.OndrovicovaG.StojkovicovaB.BauerJ. A.Bauerova-HlinkovaV.et al (2022). Mitochondrial processing peptidases-structure, function and the role in human diseases. Int. J. Mol. Sci.23 (3), 1297. 10.3390/ijms23031297
46
KunzeM. (2023). Computational evaluation of peroxisomal targeting signals in metazoa. Methods Mol. Biol.2643, 391–404. 10.1007/978-1-0716-3048-8_28
47
KuraviK.NagotuS.KrikkenA. M.SjollemaK.DeckersM.ErdmannR.et al (2006). Dynamin-related proteins Vps1p and Dnm1p control peroxisome abundance in Saccharomyces cerevisiae. J. Cell Sci.119 (19), 3994–4001. 10.1242/jcs.03166
48
LazarowP. B.FujikiY. (1985). Biogenesis of peroxisomes. Annu. Rev. Cell Biol.1, 489–530. 10.1146/annurev.cb.01.110185.002421
49
LeonS.GoodmanJ. M.SubramaniS. (2006). Uniqueness of the mechanism of protein import into the peroxisome matrix: transport of folded, co-factor-bound and oligomeric proteins by shuttling receptors. Biochim. Biophys. Acta1763 (12), 1552–1564. 10.1016/j.bbamcr.2006.08.037
50
LiX.GouldS. J. (2002). PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol.156 (4), 643–651. 10.1083/jcb.200112028
51
LingardM. J.TreleaseR. N. (2006). Five Arabidopsis peroxin 11 homologs individually promote peroxisome elongation, duplication or aggregation. J. Cell Sci.119 (9), 1961–1972. 10.1242/jcs.02904
52
LiuX.WenX.KlionskyD. J. (2018). Endoplasmic reticulum–mitochondria contacts are required for pexophagy in Saccharomyces cerevisiae. Contact2, 2158. Thousand Oaks) 2. 10.1177/2515256418821584
53
LorenzP.MaierA. G.BaumgartE.ErdmannR.ClaytonC. (1998). Elongation and clustering of glycosomes in Trypanosoma brucei overexpressing the glycosomal Pex11p. EMBO J.17 (13), 3542–3555. 10.1093/emboj/17.13.3542
54
MaierA.LorenzP.VonckenF.ClaytonC. (2001). An essential dimeric membrane protein of trypanosome glycosomes. Mol. Microbiol.39 (6), 1443–1451. 10.1046/j.1365-2958.2001.02333.x
55
MarshallP. A.DyerJ. M.QuickM. E.GoodmanJ. M. (1996). Redox-sensitive homodimerization of Pex11p: a proposed mechanism to regulate peroxisomal division. J. Cell Biol.135 (1), 123–137. 10.1083/jcb.135.1.123
56
Mattiazzi UsajM.BrloznikM.KaferleP.ZitnikM.WolinskiH.LeitnerF.et al (2015). Genome-wide localization study of yeast Pex11 identifies peroxisome-mitochondria interactions through the ERMES complex. J. Mol. Biol.427 (11), 2072–2087. 10.1016/j.jmb.2015.03.004
57
MayerhoferP. U. (2016). Targeting and insertion of peroxisomal membrane proteins: eR trafficking versus direct delivery to peroxisomes. Biochim. Biophys. Acta1863 (5), 870–880. 10.1016/j.bbamcr.2015.09.021
58
McNewJ. A.GoodmanJ. M. (1994). An oligomeric protein is imported into peroxisomes in vivo. J. Cell Biol.127 (5), 1245–1257. 10.1083/jcb.127.5.1245
59
MeineckeM.BartschP.WagnerR. (2016). Peroxisomal protein import pores. Biochim. Biophys. Acta1863 (5), 821–827. 10.1016/j.bbamcr.2015.10.013
60
MotleyA. M.HettemaE. H. (2007). Yeast peroxisomes multiply by growth and division. J. Cell Biol.178 (3), 399–410. 10.1083/jcb.200702167
61
MoyersoenJ.ChoeJ.FanE.HolW. G.MichelsP. A. (2004). Biogenesis of peroxisomes and glycosomes: trypanosomatid glycosome assembly is a promising new drug target. FEMS Microbiol. Rev.28 (5), 603–643. 10.1016/j.femsre.2004.06.004
62
MurphyM. A.PhillipsonB. A.BakerA.MullenR. T. (2003). Characterization of the targeting signal of the Arabidopsis 22-kD integral peroxisomal membrane protein. Plant Physiol.133 (2), 813–828. 10.1104/pp.103.027870
63
NeuhausA.KooshapurH.WolfJ.MeyerN. H.MadlT.SaidowskyJ.et al (2014). A novel Pex14 protein-interacting site of human Pex5 is critical for matrix protein import into peroxisomes. J. Biol. Chem.289 (1), 437–448. 10.1074/jbc.M113.499707
64
NuebelE.MorganJ. T.FogartyS.WinterJ. M.LettlovaS.BergJ. A.et al (2021). The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder. EMBO Rep.22 (10), e51991. 10.15252/embr.202051991
65
OpalinskiL.SongJ.PriesnitzC.WenzL. S.OeljeklausS.WarscheidB.et al (2018). Recruitment of cytosolic J-proteins by TOM receptors promotes mitochondrial protein biogenesis. Cell Rep.25 (8), 2036–2043.e5. 10.1016/j.celrep.2018.10.083
66
OpperdoesF. R.BorstP. (1977). Localization of nine glycolytic enzymes in a microbody-like organelle in trypanosoma brucei: the glycosome. FEBS Lett.80 (2), 360–364. 10.1016/0014-5793(77)80476-6
67
OrthT.ReumannS.ZhangX.FanJ.WenzelD.QuanS.et al (2007). The PEROXIN11 protein family controls peroxisome proliferation in Arabidopsis. Plant Cell19 (1), 333–350. 10.1105/tpc.106.045831
68
PlattaH. W.GirzalskyW.ErdmannR. (2004). Ubiquitination of the peroxisomal import receptor Pex5p. Biochem. J.384 (1), 37–45. 10.1042/BJ20040572
69
PlattaH. W.GrunauS.RosenkranzK.GirzalskyW.ErdmannR. (2005). Functional role of the AAA peroxins in dislocation of the cycling PTS1 receptor back to the cytosol. Nat. Cell Biol.7 (8), 817–822. 10.1038/ncb1281
70
ReichleR. E.AlexanderJ. V. (1965). Multiperforate septations, Woronin bodies, and septal plugs in Fusarium. J. Cell Biol.24 (3), 489–496. 10.1083/jcb.24.3.489
71
RhodinJ. (1954). “Correlation of ultrastructural organization: and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney: an electron microscopic study,” (Sweden: Dept. of Anatomy, Karolinska Institutet). PhD Thesis.
72
RottensteinerH.KramerA.LorenzenS.SteinK.LandgrafC.Volkmer-EngertR.et al (2004). Peroxisomal membrane proteins contain common Pex19p-binding sites that are an integral part of their targeting signals. Mol. Biol. Cell15 (7), 3406–3417. 10.1091/mbc.e04-03-0188
73
RottensteinerH.SteinK.SonnenholE.ErdmannR. (2003). Conserved function of pex11p and the novel pex25p and pex27p in peroxisome biogenesis. Mol. Biol. Cell14 (10), 4316–4328. 10.1091/mbc.e03-03-0153
74
RucktaschelR.ThomsS.SidorovitchV.HalbachA.PechlivanisM.VolkmerR.et al (2009). Farnesylation of pex19p is required for its structural integrity and function in peroxisome biogenesis. J. Biol. Chem.284 (31), 20885–20896. 10.1074/jbc.M109.016584
75
SackstederK. A.JonesJ. M.SouthS. T.LiX.LiuY.GouldS. J. (2000). PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J. Cell Biol.148 (5), 931–944. 10.1083/jcb.148.5.931
76
SaveriaT.HalbachA.ErdmannR.Volkmer-EngertR.LandgrafC.RottensteinerH.et al (2007). Conservation of PEX19-binding motifs required for protein targeting to mammalian peroxisomal and trypanosome glycosomal membranes. Eukaryot. Cell6 (8), 1439–1449. 10.1128/EC.00084-07
77
SchneiderK.ZimmerD.NielsenH.HerrmannJ. M.MuhlhausT. (2021). iMLP, a predictor for internal matrix targeting-like sequences in mitochondrial proteins. Biol. Chem.402 (8), 937–943. 10.1515/hsz-2021-0185
78
SchraderM.CostelloJ.GodinhoL. F.IslingerM. (2015). Peroxisome-mitochondria interplay and disease. J. Inherit. Metab. Dis.38 (4), 681–702. 10.1007/s10545-015-9819-7
79
SchraderM.CostelloJ. L.GodinhoL. F.AzadiA. S.IslingerM. (2016). Proliferation and fission of peroxisomes - an update. Biochim. Biophys. Acta1863 (5), 971–983. 10.1016/j.bbamcr.2015.09.024
80
SchraderM.ReuberB. E.MorrellJ. C.Jimenez-SanchezG.ObieC.StrohT. A.et al (1998). Expression of PEX11beta mediates peroxisome proliferation in the absence of extracellular stimuli. J. Biol. Chem.273 (45), 29607–29614. 10.1074/jbc.273.45.29607
81
SchraderT. A.CarmichaelR. E.IslingerM.CostelloJ. L.HackerC.BonekampN. A.et al (2022). PEX11β and FIS1 cooperate in peroxisome division independently of mitochondrial fission factor. J. Cell Sci.135 (13), jcs259924. 10.1242/jcs.259924
82
SouthS. T.GouldS. J. (1999). Peroxisome synthesis in the absence of preexisting peroxisomes. J. Cell Biol.144 (2), 255–266. 10.1083/jcb.144.2.255
83
SulterG. J.VerheydenK.MannaertsG.HarderW.VeenhuisM. (1993). The in vitro permeability of yeast peroxisomal membranes is caused by a 31 kDa integral membrane protein. Yeast9 (7), 733–742. 10.1002/yea.320090707
84
SwinkelsB. W.GouldS. J.BodnarA. G.RachubinskiR. A.SubramaniS. (1991). A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J.10 (11), 3255–3262. 10.1002/j.1460-2075.1991.tb04889.x
85
TamY. Y.Torres-GuzmanJ. C.VizeacoumarF. J.SmithJ. J.MarelliM.AitchisonJ. D.et al (2003). Pex11-related proteins in peroxisome dynamics: a role for the novel peroxin Pex27p in controlling peroxisome size and number in Saccharomyces cerevisiae. Mol. Biol. Cell14 (10), 4089–4102. 10.1091/mbc.e03-03-0150
86
ThomsS.GartnerJ. (2012). First PEX11β patient extends spectrum of peroxisomal biogenesis disorder phenotypes. J. Med. Genet.49 (5), 314–316. 10.1136/jmedgenet-2012-100899
87
ToroA. A.ArayaC. A.CordovaG. J.ArredondoC. A.CardenasH. G.MorenoR. E.et al (2009). Pex3p-dependent peroxisomal biogenesis initiates in the endoplasmic reticulum of human fibroblasts. J. Cell Biochem.107 (6), 1083–1096. 10.1002/jcb.22210
88
TylerK. M.MatthewsK. R.GullK. (2001). Anisomorphic cell division by African trypanosomes. Protist152 (4), 367–378. 10.1078/1434-4610-00074
89
Van AelE.FransenM. (2006). Targeting signals in peroxisomal membrane proteins. Biochim. Biophys. Acta1763 (12), 1629–1638. 10.1016/j.bbamcr.2006.08.020
90
van RoermundC. W.TabakH. F.van Den BergM.WandersR. J.HettemaE. H. (2000). Pex11p plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae. J. Cell Biol.150 (3), 489–498. 10.1083/jcb.150.3.489
91
VernerZ.ZarskyV.LeT.NarayanasamyR. K.RadaP.RozbeskyD.et al (2021). Anaerobic peroxisomes in Entamoeba histolytica metabolize myo-inositol. PLoS Pathog.17 (11), e1010041. 10.1371/journal.ppat.1010041
92
VogtleF. N.MeisingerC. (2021). Mitochondria as emergency landing for abandoned peroxins. EMBO Rep.22 (10), e53790. 10.15252/embr.202153790
93
VonckenF.van HellemondJ. J.PfistererI.MaierA.HillmerS.ClaytonC. (2003). Depletion of GIM5 causes cellular fragility, a decreased glycosome number, and reduced levels of ether-linked phospholipids in trypanosomes. J. Biol. Chem.278 (37), 35299–35310. 10.1074/jbc.M301811200
94
YoshidaY.NiwaH.HonshoM.ItoyamaA.FujikiY. (2015). Pex11mediates peroxisomal proliferation by promoting deformation of the lipid membrane. Biol. Open4 (6), 710–721. 10.1242/bio.201410801
95
Zientara-RytterK. M.MahalingamS. S.FarreJ. C.CarolinoK.SubramaniS. (2022). Recognition and chaperoning by Pex19, followed by trafficking and membrane insertion of the peroxisome proliferation protein, Pex11. Cells11 (1), 157. 10.3390/cells11010157
Summary
Keywords
peroxisome, glycosome, peroxin, PEX19, PMP, mPTS, MTS
Citation
Krishna CK, Schmidt N, Tippler BG, Schliebs W, Jung M, Winklhofer KF, Erdmann R and Kalel VC (2023) Molecular basis of the glycosomal targeting of PEX11 and its mislocalization to mitochondrion in trypanosomes. Front. Cell Dev. Biol. 11:1213761. doi: 10.3389/fcell.2023.1213761
Received
28 April 2023
Accepted
03 August 2023
Published
17 August 2023
Volume
11 - 2023
Edited by
Nathan Alder, University of Connecticut, United States
Reviewed by
Dejana Mokranjac, Ludwig Maximilian University of Munich, Germany
Richard Rachubinski, University of Alberta, Canada
Updates

Check for updates
Copyright
© 2023 Krishna, Schmidt, Tippler, Schliebs, Jung, Winklhofer, Erdmann and Kalel.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ralf Erdmann, ralf.erdmann@rub.de; Vishal C. Kalel, vishal.kalel@rub.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.